$莱斯康制药(LXRX)$ 8-K - Current report Filed: 2016-11-07 AccNo: 0001062822-16-000081 Size: 116 KBItem 1.01: Entry into a Material Definitive AgreementItem 9.01: Financial Statements and Exhibits 网页链接